Digital Translucence: Adapting Telemedicine Delivery Post-COVID-19
Telemedicine has the potential to expand the reach and capabilities of clinical care ranging from delivering care in rural settings
Read moreAbstract 205: Does Overuse of Telemetry Impede Cost-effective Patient Care?
Background: Telemetry was first introduced in the 1950s in cardiac intensive care units (ICU) and has since expanded to beyond
Read moreLayperson Telepresenters: Increasing Capacity for Telehealth in Underserved Communities
Telemedicine and e-Health, Ahead of Print. Source link
Read moreAbstract 224: Implementation of an Actionable EHR-based Population Health Dashboard and Curriculum in a Cardiovascular Disease Fellowship
Background: The advent of learning healthcare systems requires physicians to not only manage individual patients, but also use data to
Read moreComparison and Combination of Single-Lead ECG and Photoplethysmography Algorithms for Wearable-Based Atrial Fibrillation Screening
Background:Atrial fibrillation (AF), the most common cardiac arrhythmia, can be detected by smartphones and smartwatches. Introduction:Single-lead ECGs (iECGs) and photoplethysmography
Read moreAbstract 367: Are We Over-utilizing Echocardiogram for the Evaluation of Syncope Patients?
Background: Syncope is one of the most common reasons for emergency department visits. The most common causes of syncope include
Read moreAbstract 241: Health-related Quality of Life in Patients With Recurrent Pericarditis: Results From a Phase 2 Study of Rilonacept
Background: Recurrent pericarditis (RP) episodes and conventional treatments result in morbidity, but the impact on patient health-related quality of life
Read moreAbstract 26: Scenario Analyses of Lifetime Cost-effectiveness of Icosapent Ethyl in REDUCE-IT
Background: The Reduction of Cardiovascular Events with Icosapent Ethyl (IE)–Intervention Trial (REDUCE-IT) showed that patients with elevated baseline triglyceride and
Read moreComorbid Conditions and Health-Related Quality of Life in Ambulatory Heart Failure Patients
Introduction Ambulatory patients with advanced heart failure (HF) treated with oral medical therapy have comparable survival to those undergoing left
Read morePhosphodiesterase 9a Inhibition in Mouse Models of Diastolic Dysfunction
What Is New? In a mouse model of diastolic dysfunction, chronic PDE9a (Phosphodiesterase 9a) inhibition increases cGMP-PKG activity in left
Read more